SHELL ASSET MANAGEMENT CO - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$648
+4.0%
5,347
-1.7%
0.03%
+8.0%
Q2 2023$623
+3.8%
5,440
+25.1%
0.02%0.0%
Q1 2023$600
+6.0%
4,350
-0.3%
0.02%0.0%
Q4 2022$566
-99.9%
4,365
-16.8%
0.02%
+8.7%
Q3 2022$580,000
+16.9%
5,245
-20.7%
0.02%
+53.3%
Q2 2022$496,000
+15.9%
6,616
+20.7%
0.02%
+50.0%
Q1 2022$428,000
-24.5%
5,481
-12.9%
0.01%
-16.7%
Q4 2021$567,000
-2.2%
6,293
+0.4%
0.01%
-7.7%
Q3 2021$580,000
+14.2%
6,267
-4.1%
0.01%
+30.0%
Q2 2021$508,000
+85.4%
6,537
+77.8%
0.01%
+100.0%
Q1 2021$274,000
-79.3%
3,677
-52.7%
0.01%
-81.5%
Q4 2020$1,326,000
+24.0%
7,776
+2.1%
0.03%
+8.0%
Q3 2020$1,069,000
-26.6%
7,613
-16.2%
0.02%
-30.6%
Q2 2020$1,457,000
+84.9%
9,086
+12.8%
0.04%
+63.6%
Q1 2020$788,000
-37.4%
8,055
-17.4%
0.02%
-18.5%
Q4 2019$1,258,000
+111.1%
9,752
+23.3%
0.03%
+92.9%
Q3 2019$596,000
-68.7%
7,910
-36.9%
0.01%
-66.7%
Q2 2019$1,904,000
+25.9%
12,532
-1.2%
0.04%
+27.3%
Q1 2019$1,512,000
+106.0%
12,683
+88.6%
0.03%
+83.3%
Q4 2018$734,000
-38.0%
6,724
-8.2%
0.02%
-21.7%
Q3 2018$1,183,000
+22.2%
7,3240.0%0.02%
+15.0%
Q2 2018$968,000
+69.2%
7,324
-5.1%
0.02%
+81.8%
Q1 2018$572,000
+33.3%
7,7150.0%0.01%
+22.2%
Q4 2017$429,0007,7150.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders